American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6401)
  2. Solid Tumor Oncology Division (5539)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1354)
  10. Hematologic Malignancies, Division of (1281)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2583)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6401)
  2. Solid Tumor Oncology Division (5539)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (280)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8697)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (9)

More Publications

Results (9172)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
    Journal Article

    Jagannath, S.; Martin, T. G.; Lin, Y.; Cohen, A. D.; Raje, N.; Htut, M.; Deol, A.; Agha, M.; Berdeja, J. G.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma
    Journal Article

    Liu, J. F.; Colombo, N.; Oza, A. M.; Frenel, J. S.; Corr, B. R.; Rubinstein, M. M.; Nevadunsky, N. S.; Lheureux, S.; Gaba, L.; González Cortijo, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Neoadjuvant osimertinib for resectable EGFR-mutated non-small cell lung cancer
    Journal Article

    He, J.; Tsuboi, M.; Weder, W.; Chen, K. N.; Hochmair, M. J.; Shih, J. Y.; Lee, S. Y.; Lee, K. Y.; Nhung, N. V.; Saeteng, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Nivolumab-AVD versus brentuximab vedotin-AVD in older patients with advanced-stage classic Hodgkin Lymphoma enrolled on S1826
    Journal Article

    Rutherford, S. C.; Li, H.; Herrera, A. F.; Leblanc, M.; Ahmed, S.; Davison, K.; Parsons, S. K.; Unger, J. M.; Perry, A. M.; Casulo, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
    Guidelines

    Perez, K.; Del Rivero, J.; Kennedy, E. B.; Basu, S.; Chauhan, A.; Connolly, H. M.; Dasari, A. N.; Gangi, A.; Clarke, C. N.; Hallet, J.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Medically integrated dispensing pharmacy: ASCO-network for collaborative oncology development & advancement standards update
    Journal Article

    Raez, L. E.; Gregg, X. T.; Doshi, G. K.; Freeswick, S.; Cox, A.; Dave, N.; Patel, K. B.; Dillmon, M. S.; Genschaw, S.; Bettencourt, E. V.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Phase III trial of pirtobrutinib versus idelalisib/rituximab or bendamustine/rituximab in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (BRUIN CLL-321)
    Journal Article

    Sharman, J. P.; Munir, T.; Grosicki, S.; Roeker, L. E.; Burke, J. M.; Chen, C. I.; Grzasko, N.; Follows, G.; Mátrai, Z.; Sanna, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Enduring economic effects of a cancer diagnosis in adolescence and young adulthood
    Editorial

    Friedman, D. N.; Thom, B.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab and chemotherapy versus chemotherapy in advanced metastatic gastroesophageal adenocarcinoma: The phase III, randomized LEAP-015 study
    Journal Article

    Shitara, K.; Lorenzen, S.; Li, J.; Bai, Y. X.; Fernández, M. G.; Aguilar, M.; Shoji, H.; Reyes-Cosmelli, F.; Peña, Y. R.; Corrales, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Zipalertinib in patients with epidermal growth factor receptor exon 20 insertion-positive non-small cell lung cancer previously treated with platinum-based chemotherapy with or without amivantamab
    Journal Article

    Piotrowska, Z.; Passaro, A.; Nguyen, D.; Ruiter, G.; Soo, R. A.; Lee, V. H. F.; Velcheti, V.; Tan, D. S. W.; Lee, S. H.; Kim, S. H.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save